Sunday, April 23, 2017 3:10:14 PM
China pharma poised for explosive growth, Novartis CEO says
April 19th, 2017
http://www.fiercepharma.com/pharma/china-set-for-a-pharma-boom-period-novartis-ceo-says
As drugmakers face growth challenges in the U.S. and other developed countries, China is looking more enticing to one CEO. Novartis chief Joe Jimenez thinks the market is set for a boom period as the industry launches a wave of new meds in the country.
Already the second-largest pharma market in the world, Jimenez told Bloomberg that pharma sales in China could pass $300 billion by 2020. That will happen as regulators in the country push to offer new drugs to sick patients who’ve traditionally not had access to the world’s groundbreaking meds.
Last month, officials in China proposed a slate of changes to the country’s drug approval process to speed foreign drug approvals by loosening testing rules. Traditionally, drugmakers have faced high barriers to entry in China centered around local drug testing.
RELATED: China proposes new FDA rules to speed up foreign drug approvals
But with those laws set for a change, Big Pharma is taking notice.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM